Teva Pharmaceutical, Allergan PLC Deal May Close next Month; Here’s What Lies Next – Bidness ETC


Bidness ETC
Teva Pharmaceutical, Allergan PLC Deal May Close next Month; Here’s What Lies Next
Bidness ETC
Teva Pharmaceuticals Industries Ltd. (NYSE:TEVA) still appears to be on track to close the $40.5-billion acquisition of Allergan’s generic drug business by June this year. The deal is still under the Federal Trade Commission’s (FTC) review, which seeks
Teva Pharmaceutical (TEVA) Finalizes Asset Sale to Clear Allergan Generic Portfolio PurchaseInvestorGuide
Will Teva Pharmaceutical Industries Ltd (ADR) Short Squeeze Soon?B.O.D.Y Confidential
Drug company Endo’s shares drop 41% after profit forecast cutIrish Times

all 32 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd